WIPO Publishes Provectus Pharmaceuticals-Pfizer Patent: Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment Of Cancer

Sep. 20, 2012 7:27 PM ETPVCT, PFE
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Contributor Since 2012

Note: I and others entered into a securities transaction with Provectus in March 2017. Please see my blog's Disclosures page and/or refer Provectus' Securities and Exchange Commission filings for further, future disclosures {Added 3/27/17}. ---- Entrepreneurship through corporate development and investment management. Board and advisory roles, portfolio management, private equity, trading, senior and start-up company management, and venture capital. Aerospace & defense, biotechnology, financial services, gaming, healthcare, nanotechnology, private wealth management. It's only work if somebody makes you do it (Calvin) Dominic Rodrigues

Taken From Connecting The Dots...Provectus Pharmaceuticals (September 20, 2012).

Just out. More later...

Disclosure: I am long OTC:PVCT.

Additional disclosure: I am a large shareholder of Provectus Pharmaceuticals. I have not sold any shares as of this Instablog submission.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.